Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional study

Table 3 Prevalence of HBsAg and anti-HCV among NCD screening participants aged 15–64 (N = 4,459) compared to age-standardized prevalence in the general population

	Prevalence among NCD screening participants aged 15–64 years		^aPrevalence from RPHIA participants aged 15–64
Infection by Sex	Crude prevalence and 95% CI	^aDirectly standardized to the age distribution of the Rwandan Population Based HIV Impact Assessment 2018–2019	^aPrevalence from RPHIA participants aged 15–64
HBsAg
Female	1.8% (1.3%, 2.3%)	1.7%	1.3%
Male	3.3% (2.2%, 4.7%)	2.4%	2.8%
Total	2.1% (1.7%, 2.6%)	1.8%	2.0%
Anti-HCV
Female	2.7% (2.2%, 3.3%)	1.0%	1.1%
Male	2.6% (1.7%, 3.9%)	0.9%	1.3%
Total	2.7% (2.2%, 3.2%)	1.0%	1.2%

^aData on the age distribution and age- and sex-specific hepatitis prevalence extracted from the Rwandan Population- base HIV Impact Assessment 2018–2019

ISSN: 1471-2334